#Healthcare #Technology
Seeks to Address Aging Population Needs (ASX: COH.AX) (OTCQB: $INND) (OTC: $GNBT)
(NASDAQ: $ONVO)
Point Roberts WA,
Delta BC –April 23, 2019 - Investorideas.com, a leading investor
news resource covering technology and healthcare stocks releases a snapshot
looking at how the growing global aging population is inciting the health-tech
industry to create innovative solutions to address growing concerns affecting
this demographic, whether through hearing aids, oral aids or CBD oil.
According to Acumen Research and Consulting, the global Ear-Nose-Throat
(ENT) devices market is forecast
to grow at a stable CAGR around 8% during the period 2018 to 2026. In the
report named “Ear-Nose-Throat (ENT) Devices Market” - Global Industry Analysis,
Growth, Share, Size, Trends and Forecast, 2018-2026”, rising incorporation of
advanced technology, growing awareness about various health related issues,
ever-increasing healthcare costs, favorable regulatory backdrop for ENT
devices, increasing geriatric population, technological advancements,
user-friendly ENT devices changing lifestyle patterns and ease of availability
of various ear-nose-throat devices are some of the key factors that are
fuelling the ear-nose-throat devices market growth across the globe.
Read
this in full at
This was reaffirmed in the The
State of Hearing Report
conducted for Cochlear
Limited (ASX: COH), which revealed that many people know that adults
with hearing loss are facing social isolation, declining self-esteem and losing
the ability to communicate as their families feel the strain and that a
solution could start by people simply changing how they think about hearing
loss and recognizing it can often be preventable and treatable.
InnerScope
Hearing Technologies Inc. (OTCQB: INND), a manufacturer and
Direct-to-Consumer distributor/retailer of FDA-Registered Hearing Aids,
Personal Sound Amplifier Products, Hearing
Related Treatment Therapies, Doctor-Formulated Dietary Hearing Supplements
and proprietary CBD Oil, recently announced that it has entered into an
Agreement with AsSeenOnTV.pro to produce Direct
Response TV and Brand Response TV commercials promoting its Self-Fitting Hearing
Aids (“NEXUS”), Dietary Hearing Supplements “Nutrition for the Ears” and CBD
Oil. The Hearing Product Commercials will feature Kevin Harrington, the pioneer of the ‘As
Seen On TV’ empire and an original “Shark” from the Emmy award-winning TV
reality show, Shark Tank. Kevin
Harrington is also the Co-Executive Producer and the mastermind behind
AsSeenOnTV.pro DRTV/BRTV campaigns.
Mr. Harrington commented
“Having known and worked with the founders of InnerScope in the past, I know
their passion and expertise in helping the tens of millions of people that have
hearing related problems. With 48
million people in the US alone that have reported having hearing issues,
InnerScope’s Hearing Aids and Hearing Health Products have mass-market appeal.
This is one of the reasons my team thinks InnerScope is a good fit to create an
Omni-Channel TV/Video Media Campaign to target those tens of millions potential
customers.”
Generex Biotechnology Corporation (OTC: GNBT), who, through its subsidiaries engages
in the administration of formulations of large molecule drugs to the oral
cavity, recently announced that the company’s
subsidiary Olaregen Therapeutix participated as a sponsor of the prestigious
Diabetic Limb Salvage Conference in Washington, DC as part of its continued
commitment to Wound Care Education. The Conference was attended by 600
influential experts and healthcare providers involved in the research and
management of wounds, with specific emphasis on diabetic foot ulcers (DFUs).
Olaregen hosted an exhibit to present information on its now commercial wound
care product, Excellagen®, formulated fibrillar collagen (2.6%) wound
conforming matrix, indicated for the management of several wound types,
significant among them, DFUs.
Organovo Holdings, Inc. (NASDAQ: ONVO), a biotechnology
company pioneering the development of 3D bio-printed tissues aimed at treating
a range of serious adult and pediatric liver diseases, announced that Chief Medical
Officer, Dr. Steven G. Hughes is scheduled to speak at the inaugural Cell &
Gene Meeting on the Mediterranean to be held April 23-25 in Barcelona, Spain.
This event, modeled
after The Alliance for Regenerative Medicine’s (“ARM”) highly successful Cell
& Gene Meeting on the Mesa held annually in La Jolla, California, is
expected to attract more than 250 attendees, including senior executives from
leading cell therapy, gene therapy, and tissue engineering companies worldwide,
large pharma and biotech representatives, institutional investors, academic
research institutions, patient foundations, disease philanthropies and members
of the life science media community.
This “new age trend”
of focusing on awareness and access with regards to healthcare technology for
this expanding, aging population is proving to be a valued component for the
industry. It’s now “good business” to care for our elders.
For investors
following medical technology and healthcare stocks, Investor Ideas has created a directory of biotech and medical technology
stocks
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and
Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Follow us on Social Media
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Disclosure: this news article featuring InnerScope Hearing Technologies is a paid for service on Investorideas.com(third
party)
Contact management and IR of each company directly
regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800-665-0411
